North America Nuclear Medicine Diagnostics Market Growth, Trends, and Forecasts (2016–2021)
North America Nuclear Medicine Diagnostics Market by SPECT, by Application (cardiology, lymphoma, thyroid, neurology, oncology) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
(EMAILWIRE.COM, May 10, 2018 ) The North America nuclear medicine diagnostic market is estimated at $3.54 billion in 2015 and is expected to reach $6.04 billion by 2020, at a compound annual growth rate (CAGR) of 11.3%.Nuclear medicine is a branch of medicine that uses radiation to deliver information about the functioning of a person's specific organs or to treat a disease. In most cases, the information will assist the physicians to make a quick, accurate diagnosis of the patient's illness.
Browse Full Report with TOC: https://marketdataforecast.com/market-reports/north-america-nuclear-medicine-diagnostics-market-124/
Till now, SPECT imaging was the most conventional modality for nuclear medicine applications such as nuclear cardiology procedures. However, the trend is soon going to see a down turn owing to shortage of molybdenum-99 isotope which in turn will lead to deficiency of Technetium-99, which is the by-product of molybdenum. Therefore, PET imaging products which include hybrid PET-CT scanners is estimated to be the fastest growing and expected to account for a potentially hefty share in the near future.
The emerging market affinity is expected to be a fusion of nuclear imaging with different diagnostic imaging products such as SPECT/CT, PET/CT and MRI/PET. This provides full range of imaging scans through the same unit and at the same time. PET market is expected to witness additional growth compared to SPECT imaging due to its better features of delivering higher resolution images and the lack of availability of technetium-99m.
Get Free Sample Copy of Report: https://marketdataforecast.com/market-reports/north-america-nuclear-medicine-diagnostics-market-124/request-sample
Increasing usage of SPECT and PET in medical diagnostics, rising awareness among people about radiopharmaceuticals, and ready availability of radiopharmaceuticals are some of the major factors fuelling the growth of the market.However, shorter half- life of radioisotopes, regulatory guidelines, high capital investment and reimbursement issues are acting as restraints for the nuclear medicine market growth.
The Nuclear Medicine Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Iodine (I-123) Thallium-201 (TL-201) and others) and PET (Rubidium-82 (RB-82), Fluorine-18, and others). By application, the market is categorized into SPECT (lymphoma, cardiology, neurology, thyroid and others) and PET (cardiology, oncology, neurology and others).
Furthermore, on the basis of geography, the North American market for nuclear diagnostics is analysed under two regions namely, USA and Canada.
Browse Customize before buying: https://marketdataforecast.com/market-reports/north-america-nuclear-medicine-diagnostics-market-124/customize-report
Market Segmentation
By Type
• SPECT
i. Technetium-99m
ii. Thallium-201
iii. Gallium-67
iv. Iodine-23
v. Others
• PET
1. Fluorine-18
2. Rubidium-82
3. Others
By Application
• Cardiology
• Lymphoma
• Thyroid
• Neurology
• Oncology
• Others
Scope of the report
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Browse Full Report with TOC: https://marketdataforecast.com/market-reports/north-america-nuclear-medicine-diagnostics-market-124/
Till now, SPECT imaging was the most conventional modality for nuclear medicine applications such as nuclear cardiology procedures. However, the trend is soon going to see a down turn owing to shortage of molybdenum-99 isotope which in turn will lead to deficiency of Technetium-99, which is the by-product of molybdenum. Therefore, PET imaging products which include hybrid PET-CT scanners is estimated to be the fastest growing and expected to account for a potentially hefty share in the near future.
The emerging market affinity is expected to be a fusion of nuclear imaging with different diagnostic imaging products such as SPECT/CT, PET/CT and MRI/PET. This provides full range of imaging scans through the same unit and at the same time. PET market is expected to witness additional growth compared to SPECT imaging due to its better features of delivering higher resolution images and the lack of availability of technetium-99m.
Get Free Sample Copy of Report: https://marketdataforecast.com/market-reports/north-america-nuclear-medicine-diagnostics-market-124/request-sample
Increasing usage of SPECT and PET in medical diagnostics, rising awareness among people about radiopharmaceuticals, and ready availability of radiopharmaceuticals are some of the major factors fuelling the growth of the market.However, shorter half- life of radioisotopes, regulatory guidelines, high capital investment and reimbursement issues are acting as restraints for the nuclear medicine market growth.
The Nuclear Medicine Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Iodine (I-123) Thallium-201 (TL-201) and others) and PET (Rubidium-82 (RB-82), Fluorine-18, and others). By application, the market is categorized into SPECT (lymphoma, cardiology, neurology, thyroid and others) and PET (cardiology, oncology, neurology and others).
Furthermore, on the basis of geography, the North American market for nuclear diagnostics is analysed under two regions namely, USA and Canada.
Browse Customize before buying: https://marketdataforecast.com/market-reports/north-america-nuclear-medicine-diagnostics-market-124/customize-report
Market Segmentation
By Type
• SPECT
i. Technetium-99m
ii. Thallium-201
iii. Gallium-67
iv. Iodine-23
v. Others
• PET
1. Fluorine-18
2. Rubidium-82
3. Others
By Application
• Cardiology
• Lymphoma
• Thyroid
• Neurology
• Oncology
• Others
Scope of the report
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results